MicroRNAs in the bile of patients with biliary strictures after liver transplantation

Liver Transplantation

Volumn 20, Issue 6, 2014, Pages 673-678

  Lankisch, Tim O ^a   Voigtländer, Torsten ^a   Manns, Michael P ^a   Holzmann, Angelika ^a   Dangwal, Seema ^a   Thum, Thomas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 106A; MICRORNA 210; MICRORNA 329; MICRORNA 3375P; MICRORNA 517A; MICRORNA 577; MICRORNA 892A; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG; GENETIC MARKER; MIRN106 MICRORNA, HUMAN; MIRN517 MICRORNA, HUMAN; MIRN892 MICRORNA, HUMAN;

ACUTE LIVER FAILURE; ADULT; ALCOHOL LIVER CIRRHOSIS; ANASTOMOSIS STENOSIS; ANASTOMOTIC STRICTURE; ARTICLE; BILE; BILE DUCT STONE; BILIARY TRACT DISEASE; CHOLESTASIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; ISCHEMIC TYPE BILIARY LESION; LABORATORY TEST; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER CYST; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; SURGICAL PATIENT; VALIDATION STUDY; WILSON DISEASE; AGED; CHEMISTRY; GENE EXPRESSION PROFILING; GENETIC MARKER; GENETICS; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SEVERITY OF ILLNESS INDEX; UPREGULATION;

ADULT; AGED; BILE; CHOLESTASIS; CROSS-SECTIONAL STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; LIVER TRANSPLANTATION; MALE; MICRORNAS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UP-REGULATION;

EID: 84901390343     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23872     Document Type: Article

References (27)

1. Toffanin S, Sia D, Villanueva A,. MicroRNAs: new ways to block tumor angiogenesis? J Hepatol 2012; 57: 490-491.
2. Liu S, Guo W, Shi J, Li N, Yu X, Xue J, et al. MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. J Hepatol 2012; 56: 389-396.
3. Shigehara K, Yokomuro S, Ishibashi O, Mizuguchi Y, Arima Y, Kawahigashi Y, et al. Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. PLoS One 2011; 6: e23584.
4. Zoepf T, Maldonado de Dechêne EJ, Dechêne A, Malágo M, Beckebaum S, Paul A, et al. Optimized endoscopic treatment of ischemic-type biliary lesions after liver transplantation. Gastrointest Endosc 2012; 76: 556-563.
5. Frongillo F, Grossi U, Avolio AW, Sganga G, Nure E, Pepe G, et al. Factors predicting ischemic-type biliary lesions (ITBLs) after liver transplantation. Transplant Proc 2012; 44: 2002-2004.
6. Ryu CH, Lee SK,. Biliary strictures after liver transplantation. Gut Liver 2011; 5: 133-142.
7. Verdonk RC, Buis CI, Porte RJ, van der Jagt EJ, Limburg AJ, van den Berg AP, et al. Anastomotic biliary strictures after liver transplantation: causes and consequences. Liver Transpl 2006; 12: 726-735.
8. Negm AA, Schott A, Vonberg RP, Weismueller TJ, Schneider AS, Kubicka S, et al. Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc 2010; 72: 284-291.
9. Hintze RE, Abou-Rebyeh H, Adler A, Veltzke W, Langrehr J, Wiedenmann B, Neuhaus P,. Endoscopic therapy of ischemia-type biliary lesions in patients following orthotopic liver transplantation [in German]. Z Gastroenterol 1999; 37: 13-20.
10. Theilmann L, Küppers B, Kadmon M, Roeren T, Notheisen H, Stiehl A, Otto G,. Biliary tract strictures after orthotopic liver transplantation: diagnosis and management. Endoscopy 1994; 26: 517-522.
11. Gastaca M,. Biliary complications after orthotopic liver transplantation: a review of incidence and risk factors. Transplant Proc 2012; 44: 1545-1549.
12. Seehofer D, Eurich D, Veltzke-Schlieker W, Neuhaus P,. Biliary complications after liver transplantation: old problems and new challenges. Am J Transplant 2013; 13: 253-265.
13. González MR, Cascales PA, Abellán I, Pons JA, Miras M, Capel A, et al. The evolution of therapeutic strategies for biliary tract complications after liver transplantation over a period of 20 years. Transplant Proc 2012; 44: 2093-2095.
14. Yang H, Fang F, Chang R, Yang L,. MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma. Hepatology 2013; 58: 205-217.
15. Chen X, Zhang L, Zhang T, Hao M, Zhang X, Zhang J, et al. Methylation-mediated repression of microRNA 129-2 enhances oncogenic SOX4 expression in HCC. Liver Int 2013; 33: 476-486.
16. Kitagawa N, Ojima H, Shirakihara T, Shimizu H, Kokubu A, Urushidate T, et al. Downregulation of the microRNA biogenesis components and its association with poor prognosis in hepatocellular carcinoma. Cancer Sci 2013; 104: 543-551.
17. Toffanin S, Hoshida Y, Lachenmayer A, Villanueva A, Cabellos L, Minguez B, et al. MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a. Gastroenterology 2011; 140: 1618-1628.e16.
18. Choi YM, An S, Lee EM, Kim K, Choi SJ, Kim JS, et al. CYP1A1 is a target of miR-892a-mediated post-transcriptional repression. Int J Oncol 2012; 41: 331-336.
19. Cui L, Zhang X, Ye G, Zheng T, Song H, Deng H, et al. Gastric juice microRNAs as potential biomarkers for the screening of gastric cancer. Cancer 2013; 119: 1618-1626.
20. Kim BH, Hong SW, Kim A, Choi SH, Yoon SO,. Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma. J Surg Oncol 2013; 107: 505-510.
21. Catela Ivkovic T, Aralica G, Cacev T, Loncar B, Kapitanovic S,. miR-106a overexpression and pRB downregulation in sporadic colorectal cancer. Exp Mol Pathol 2013; 94: 148-154.
22. Bessho K, Shanmukhappa K, Sheridan R, Shivakumar P, Mourya R, Walters S, et al. Integrative genomics identifies candidate microRNAs for pathogenesis of experimental biliary atresia. BMC Syst Biol 2013; 7: 104.
23. Ninomiya M, Kondo Y, Funayama R, Nagashima T, Kogure T, Kakazu E, et al. Distinct microRNAs expression profile in primary biliary cirrhosis and evaluation of miR 505-3p and miR197-3p as novel biomarkers. PLoS One 2013; 8: e66086.
24. Lorenzen JM, Kielstein JT, Hafer C, Gupta SK, Kümpers P, Faulhaber-Walter R, et al. Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol 2011; 6: 1540-1546.
25. Chan YC, Banerjee J, Choi SY, Sen CK,. miR-210: the master hypoxamir. Microcirculation 2012; 19: 215-223.
26. Ying Q, Liang L, Guo W, Zha R, Tian Q, Huang S, et al. Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma. Hepatology 2011; 54: 2064-2075.
27. Yang H, Li TW, Peng J, Tang X, Ko KS, Xia M, Aller MA,. A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression. Gastroenterology 2011; 141: 378-388.